Bone Mineral Density Effects of Randomized Regimen and Nucleoside Reverse Transcriptase Inhibitor (NRTI) Selection from ACTG A5142

Benzer Materyaller

• Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI
  Yazar:: Torti, Carlo, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data
  Yazar:: Simpson, Kit N, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• In Vitro Cross-Resistance Profile of Nucleoside Reverse Transcriptase Inhibitor (NRTI) BMS-986001 against Known NRTI Resistance Mutations
  Yazar:: Li, Zhufang, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Comparative Effectiveness of Initial Antiretroviral Therapy Regimens: ACTG 5095 and 5142 Clinical Trials Relative to ART-CC Cohort Study
  Yazar:: Mugavero, Michael J., ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Failure of Initial Therapy with Two Nucleosides and Efavirenz is Not Associated with Early Emergence of Mutations in the C-Terminus of HIV-1 Reverse Transcriptase
  Yazar:: Brehm, Jessica H., ve diğerleri
  Baskı/Yayın Bilgisi: (2011)